A2M Molecule

CRN_logo_color_withtag

If you or a loved one suffers from debilitating joint pain, your doctor may suspect osteoarthritis (OA). OA is a type of joint disease that results in the breakdown and destruction of cartilage – the connective tissue located between the bones of your joints that helps maintain smooth and painless movement.

Damage to cartilage happens mechanically through physical damage, as well as biochemically. There are enzymes (commonly proteins) in your body that accelerate the breakdown of your cartilage. They are called proteases.  These enzymes are difficult to remove from your joints. In addition, this type of damage is very challenging for your body to repair or restore naturally because cartilage is “avascular” – meaning it doesn’t have a blood supply to provide vital proteins, growth factors and cells for tissue regeneration.

FACT pain diagnostic.

Research has shown that an inflammatory cascade of proteins causes back and joint pain.  A recently discovered, unique biomarker called Fibronectin-Aggrecan Complex (FAC) has been identified in the painful inflammation of spine discs and joints. A novel antibody diagnostic test called FACT is used to detect the presence of FAC from a fluid specimen taken from a painful back or joint location. Like most other laboratory tests, FACT must be ordered by your physician.

A miracle molecule.

A2M (Alpha-2-Macroglobulin) is a newly discovered compound that acts as a powerful inhibitor of cartilage breakdown.  A2M is a master protease inhibitor that exists in your blood.  It attaches to and removes the destructive proteins in the joint.

This special molecule works by binding the chemicals (proteases) that degrade the cartilage cells and tissue.

A patented and proprietary filtration process has been developed that can concentrate the naturally occurring A2M molecule in your blood up to 6X. This process allows therapeutic injections in concentrated dosages that:

  • Boost natural healing by reducing the additional deterioration of cartilage
  • Support tissue growth with naturally occurring compounds from your own blood

Early Treatment = Better Recovery

A2M is an exciting advance in orthopedic science resulting from years of osteoarthritis research. The earlier identifying signals of joint destruction are discovered, the less invasive treatments will be. Early treatments can postpone the need the need for more aggressive and costly joint reconstruction or replacement surgery.

So take control of your heath and contact us to see whether this breakthrough in orthopedic medicine, A2M, is right for your condition.